nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Vinblastine—head and neck cancer	0.321	0.413	CbGbCtD
Levetiracetam—ABCC2—Docetaxel—head and neck cancer	0.265	0.341	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—head and neck cancer	0.105	0.135	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—head and neck cancer	0.0862	0.111	CbGbCtD
Levetiracetam—Common cold—Fluorouracil—head and neck cancer	0.00853	0.0381	CcSEcCtD
Levetiracetam—Lower respiratory tract infection—Docetaxel—head and neck cancer	0.0047	0.021	CcSEcCtD
Levetiracetam—Balance disorder—Fluorouracil—head and neck cancer	0.00407	0.0182	CcSEcCtD
Levetiracetam—Raised liver function tests—Docetaxel—head and neck cancer	0.00348	0.0156	CcSEcCtD
Levetiracetam—Foetor hepaticus—Docetaxel—head and neck cancer	0.00283	0.0127	CcSEcCtD
Levetiracetam—Hepatic failure—Hydroxyurea—head and neck cancer	0.0025	0.0112	CcSEcCtD
Levetiracetam—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00238	0.0106	CcSEcCtD
Levetiracetam—Laryngeal pain—Docetaxel—head and neck cancer	0.00236	0.0105	CcSEcCtD
Levetiracetam—Liver disorder—Docetaxel—head and neck cancer	0.00236	0.0105	CcSEcCtD
Levetiracetam—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00235	0.0105	CcSEcCtD
Levetiracetam—Throat sore—Docetaxel—head and neck cancer	0.00223	0.00997	CcSEcCtD
Levetiracetam—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00221	0.00988	CcSEcCtD
Levetiracetam—Face oedema—Hydroxyurea—head and neck cancer	0.00217	0.00969	CcSEcCtD
Levetiracetam—Otitis media—Docetaxel—head and neck cancer	0.00206	0.00923	CcSEcCtD
Levetiracetam—Pancytopenia—Vinblastine—head and neck cancer	0.00202	0.00904	CcSEcCtD
Levetiracetam—Rhinorrhoea—Docetaxel—head and neck cancer	0.00198	0.00887	CcSEcCtD
Levetiracetam—Euphoric mood—Fluorouracil—head and neck cancer	0.00191	0.00855	CcSEcCtD
Levetiracetam—Pancreatitis—Hydroxyurea—head and neck cancer	0.0019	0.00851	CcSEcCtD
Levetiracetam—Depression—Vinblastine—head and neck cancer	0.00189	0.00846	CcSEcCtD
Levetiracetam—Pancytopenia—Hydroxyurea—head and neck cancer	0.00184	0.00824	CcSEcCtD
Levetiracetam—Neutropenia—Hydroxyurea—head and neck cancer	0.00182	0.00811	CcSEcCtD
Levetiracetam—Agranulocytosis—Vinblastine—head and neck cancer	0.00177	0.00792	CcSEcCtD
Levetiracetam—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00177	0.0079	CcSEcCtD
Levetiracetam—Weight increased—Hydroxyurea—head and neck cancer	0.00177	0.0079	CcSEcCtD
Levetiracetam—Drug interaction—Docetaxel—head and neck cancer	0.00173	0.00775	CcSEcCtD
Levetiracetam—Drowsiness—Hydroxyurea—head and neck cancer	0.00173	0.00774	CcSEcCtD
Levetiracetam—Infestation NOS—Hydroxyurea—head and neck cancer	0.00173	0.00774	CcSEcCtD
Levetiracetam—Infestation—Hydroxyurea—head and neck cancer	0.00173	0.00774	CcSEcCtD
Levetiracetam—Amnesia—Fluorouracil—head and neck cancer	0.00172	0.00769	CcSEcCtD
Levetiracetam—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00169	0.00756	CcSEcCtD
Levetiracetam—Pharyngitis—Vinblastine—head and neck cancer	0.00169	0.00756	CcSEcCtD
Levetiracetam—Stomatitis—Hydroxyurea—head and neck cancer	0.00169	0.00754	CcSEcCtD
Levetiracetam—Lethargy—Fluorouracil—head and neck cancer	0.00165	0.00737	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00164	0.00732	CcSEcCtD
Levetiracetam—Respiratory failure—Docetaxel—head and neck cancer	0.00164	0.00732	CcSEcCtD
Levetiracetam—Hepatocellular injury—Docetaxel—head and neck cancer	0.00161	0.00719	CcSEcCtD
Levetiracetam—Hallucination—Hydroxyurea—head and neck cancer	0.00155	0.00691	CcSEcCtD
Levetiracetam—Irritability—Fluorouracil—head and neck cancer	0.00154	0.0069	CcSEcCtD
Levetiracetam—Ataxia—Fluorouracil—head and neck cancer	0.00152	0.0068	CcSEcCtD
Levetiracetam—Alopecia—Vinblastine—head and neck cancer	0.00151	0.00673	CcSEcCtD
Levetiracetam—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00145	0.00646	CcSEcCtD
Levetiracetam—Muscular weakness—Fluorouracil—head and neck cancer	0.00143	0.00637	CcSEcCtD
Levetiracetam—Eosinophilia—Fluorouracil—head and neck cancer	0.00138	0.00618	CcSEcCtD
Levetiracetam—Alopecia—Hydroxyurea—head and neck cancer	0.00137	0.00614	CcSEcCtD
Levetiracetam—Vertigo—Vinblastine—head and neck cancer	0.00133	0.00596	CcSEcCtD
Levetiracetam—Leukopenia—Vinblastine—head and neck cancer	0.00133	0.00593	CcSEcCtD
Levetiracetam—Pancytopenia—Fluorouracil—head and neck cancer	0.00133	0.00593	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0013	0.00581	CcSEcCtD
Levetiracetam—Hepatic failure—Docetaxel—head and neck cancer	0.0013	0.0058	CcSEcCtD
Levetiracetam—Convulsion—Vinblastine—head and neck cancer	0.00128	0.00574	CcSEcCtD
Levetiracetam—Infestation NOS—Fluorouracil—head and neck cancer	0.00125	0.00557	CcSEcCtD
Levetiracetam—Infestation—Fluorouracil—head and neck cancer	0.00125	0.00557	CcSEcCtD
Levetiracetam—Renal impairment—Docetaxel—head and neck cancer	0.00123	0.00548	CcSEcCtD
Levetiracetam—Dermatitis bullous—Docetaxel—head and neck cancer	0.00122	0.00546	CcSEcCtD
Levetiracetam—Stomatitis—Fluorouracil—head and neck cancer	0.00121	0.00543	CcSEcCtD
Levetiracetam—Urinary tract infection—Fluorouracil—head and neck cancer	0.00121	0.00541	CcSEcCtD
Levetiracetam—Conjunctivitis—Fluorouracil—head and neck cancer	0.00121	0.00541	CcSEcCtD
Levetiracetam—Leukopenia—Hydroxyurea—head and neck cancer	0.00121	0.00541	CcSEcCtD
Levetiracetam—Lethargy—Docetaxel—head and neck cancer	0.00119	0.00532	CcSEcCtD
Levetiracetam—Thrombocytopenia—Vinblastine—head and neck cancer	0.00119	0.0053	CcSEcCtD
Levetiracetam—Epistaxis—Fluorouracil—head and neck cancer	0.00118	0.00525	CcSEcCtD
Levetiracetam—Convulsion—Hydroxyurea—head and neck cancer	0.00117	0.00524	CcSEcCtD
Levetiracetam—Hyponatraemia—Docetaxel—head and neck cancer	0.00117	0.00524	CcSEcCtD
Levetiracetam—Sinusitis—Fluorouracil—head and neck cancer	0.00117	0.00522	CcSEcCtD
Levetiracetam—Agranulocytosis—Fluorouracil—head and neck cancer	0.00116	0.0052	CcSEcCtD
Levetiracetam—Anorexia—Vinblastine—head and neck cancer	0.00115	0.00516	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00114	0.00511	CcSEcCtD
Levetiracetam—Rhinitis—Fluorouracil—head and neck cancer	0.00112	0.00501	CcSEcCtD
Levetiracetam—Pharyngitis—Fluorouracil—head and neck cancer	0.00111	0.00496	CcSEcCtD
Levetiracetam—Ataxia—Docetaxel—head and neck cancer	0.0011	0.0049	CcSEcCtD
Levetiracetam—Infection—Hydroxyurea—head and neck cancer	0.0011	0.0049	CcSEcCtD
Levetiracetam—Paraesthesia—Vinblastine—head and neck cancer	0.00109	0.00486	CcSEcCtD
Levetiracetam—Dehydration—Docetaxel—head and neck cancer	0.00109	0.00485	CcSEcCtD
Levetiracetam—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00108	0.00484	CcSEcCtD
Levetiracetam—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00108	0.00483	CcSEcCtD
Levetiracetam—Liver function test abnormal—Docetaxel—head and neck cancer	0.00108	0.00482	CcSEcCtD
Levetiracetam—Skin disorder—Hydroxyurea—head and neck cancer	0.00107	0.00479	CcSEcCtD
Levetiracetam—Abdominal pain upper—Docetaxel—head and neck cancer	0.00107	0.00476	CcSEcCtD
Levetiracetam—Anorexia—Hydroxyurea—head and neck cancer	0.00105	0.0047	CcSEcCtD
Levetiracetam—Decreased appetite—Vinblastine—head and neck cancer	0.00105	0.0047	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00105	0.0047	CcSEcCtD
Levetiracetam—Nasopharyngitis—Docetaxel—head and neck cancer	0.00104	0.00466	CcSEcCtD
Levetiracetam—Constipation—Vinblastine—head and neck cancer	0.00104	0.00463	CcSEcCtD
Levetiracetam—Pain—Vinblastine—head and neck cancer	0.00104	0.00463	CcSEcCtD
Levetiracetam—Feeling abnormal—Vinblastine—head and neck cancer	0.000997	0.00446	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00099	0.00442	CcSEcCtD
Levetiracetam—Alopecia—Fluorouracil—head and neck cancer	0.000988	0.00442	CcSEcCtD
Levetiracetam—Somnolence—Hydroxyurea—head and neck cancer	0.000981	0.00439	CcSEcCtD
Levetiracetam—Dyspepsia—Hydroxyurea—head and neck cancer	0.000972	0.00434	CcSEcCtD
Levetiracetam—Decreased appetite—Hydroxyurea—head and neck cancer	0.00096	0.00429	CcSEcCtD
Levetiracetam—Pancytopenia—Docetaxel—head and neck cancer	0.000958	0.00428	CcSEcCtD
Levetiracetam—Abdominal pain—Vinblastine—head and neck cancer	0.000957	0.00428	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000953	0.00426	CcSEcCtD
Levetiracetam—Fatigue—Hydroxyurea—head and neck cancer	0.000952	0.00425	CcSEcCtD
Levetiracetam—Constipation—Hydroxyurea—head and neck cancer	0.000944	0.00422	CcSEcCtD
Levetiracetam—Pain—Hydroxyurea—head and neck cancer	0.000944	0.00422	CcSEcCtD
Levetiracetam—Neutropenia—Docetaxel—head and neck cancer	0.000943	0.00422	CcSEcCtD
Levetiracetam—Weight increased—Docetaxel—head and neck cancer	0.000918	0.0041	CcSEcCtD
Levetiracetam—Vision blurred—Fluorouracil—head and neck cancer	0.000917	0.0041	CcSEcCtD
Levetiracetam—Weight decreased—Docetaxel—head and neck cancer	0.000912	0.00408	CcSEcCtD
Levetiracetam—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00091	0.00407	CcSEcCtD
Levetiracetam—Infestation NOS—Docetaxel—head and neck cancer	0.000899	0.00402	CcSEcCtD
Levetiracetam—Infestation—Docetaxel—head and neck cancer	0.000899	0.00402	CcSEcCtD
Levetiracetam—Hypersensitivity—Vinblastine—head and neck cancer	0.000892	0.00399	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000891	0.00399	CcSEcCtD
Levetiracetam—Stomatitis—Docetaxel—head and neck cancer	0.000876	0.00392	CcSEcCtD
Levetiracetam—Conjunctivitis—Docetaxel—head and neck cancer	0.000874	0.00391	CcSEcCtD
Levetiracetam—Body temperature increased—Hydroxyurea—head and neck cancer	0.000873	0.0039	CcSEcCtD
Levetiracetam—Leukopenia—Fluorouracil—head and neck cancer	0.000871	0.0039	CcSEcCtD
Levetiracetam—Asthenia—Vinblastine—head and neck cancer	0.000868	0.00388	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00085	0.0038	CcSEcCtD
Levetiracetam—Epistaxis—Docetaxel—head and neck cancer	0.000848	0.00379	CcSEcCtD
Levetiracetam—Convulsion—Fluorouracil—head and neck cancer	0.000843	0.00377	CcSEcCtD
Levetiracetam—Agranulocytosis—Docetaxel—head and neck cancer	0.000839	0.00375	CcSEcCtD
Levetiracetam—Chest pain—Fluorouracil—head and neck cancer	0.000829	0.00371	CcSEcCtD
Levetiracetam—Myalgia—Fluorouracil—head and neck cancer	0.000829	0.00371	CcSEcCtD
Levetiracetam—Diarrhoea—Vinblastine—head and neck cancer	0.000828	0.0037	CcSEcCtD
Levetiracetam—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000813	0.00364	CcSEcCtD
Levetiracetam—Rhinitis—Docetaxel—head and neck cancer	0.000809	0.00362	CcSEcCtD
Levetiracetam—Hepatitis—Docetaxel—head and neck cancer	0.000807	0.00361	CcSEcCtD
Levetiracetam—Confusional state—Fluorouracil—head and neck cancer	0.000801	0.00358	CcSEcCtD
Levetiracetam—Pharyngitis—Docetaxel—head and neck cancer	0.000801	0.00358	CcSEcCtD
Levetiracetam—Dizziness—Vinblastine—head and neck cancer	0.0008	0.00358	CcSEcCtD
Levetiracetam—Connective tissue disorder—Docetaxel—head and neck cancer	0.000793	0.00355	CcSEcCtD
Levetiracetam—Asthenia—Hydroxyurea—head and neck cancer	0.000792	0.00354	CcSEcCtD
Levetiracetam—Infection—Fluorouracil—head and neck cancer	0.000789	0.00353	CcSEcCtD
Levetiracetam—Nervous system disorder—Fluorouracil—head and neck cancer	0.000779	0.00348	CcSEcCtD
Levetiracetam—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000778	0.00348	CcSEcCtD
Levetiracetam—Vomiting—Vinblastine—head and neck cancer	0.00077	0.00344	CcSEcCtD
Levetiracetam—Erythema multiforme—Docetaxel—head and neck cancer	0.000763	0.00341	CcSEcCtD
Levetiracetam—Headache—Vinblastine—head and neck cancer	0.000758	0.00339	CcSEcCtD
Levetiracetam—Anorexia—Fluorouracil—head and neck cancer	0.000757	0.00339	CcSEcCtD
Levetiracetam—Diarrhoea—Hydroxyurea—head and neck cancer	0.000755	0.00338	CcSEcCtD
Levetiracetam—Eye disorder—Docetaxel—head and neck cancer	0.000754	0.00337	CcSEcCtD
Levetiracetam—Dizziness—Hydroxyurea—head and neck cancer	0.00073	0.00326	CcSEcCtD
Levetiracetam—Immune system disorder—Docetaxel—head and neck cancer	0.000729	0.00326	CcSEcCtD
Levetiracetam—Mediastinal disorder—Docetaxel—head and neck cancer	0.000727	0.00325	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000724	0.00324	CcSEcCtD
Levetiracetam—Nausea—Vinblastine—head and neck cancer	0.000719	0.00321	CcSEcCtD
Levetiracetam—Insomnia—Fluorouracil—head and neck cancer	0.000719	0.00321	CcSEcCtD
Levetiracetam—Paraesthesia—Fluorouracil—head and neck cancer	0.000713	0.00319	CcSEcCtD
Levetiracetam—Alopecia—Docetaxel—head and neck cancer	0.000713	0.00319	CcSEcCtD
Levetiracetam—Mental disorder—Docetaxel—head and neck cancer	0.000707	0.00316	CcSEcCtD
Levetiracetam—Somnolence—Fluorouracil—head and neck cancer	0.000706	0.00316	CcSEcCtD
Levetiracetam—Malnutrition—Docetaxel—head and neck cancer	0.000703	0.00314	CcSEcCtD
Levetiracetam—Vomiting—Hydroxyurea—head and neck cancer	0.000702	0.00314	CcSEcCtD
Levetiracetam—Dyspepsia—Fluorouracil—head and neck cancer	0.000699	0.00313	CcSEcCtD
Levetiracetam—Rash—Hydroxyurea—head and neck cancer	0.000696	0.00311	CcSEcCtD
Levetiracetam—Dermatitis—Hydroxyurea—head and neck cancer	0.000695	0.00311	CcSEcCtD
Levetiracetam—Headache—Hydroxyurea—head and neck cancer	0.000691	0.00309	CcSEcCtD
Levetiracetam—Decreased appetite—Fluorouracil—head and neck cancer	0.000691	0.00309	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000686	0.00307	CcSEcCtD
Levetiracetam—Back pain—Docetaxel—head and neck cancer	0.00068	0.00304	CcSEcCtD
Levetiracetam—Pain—Fluorouracil—head and neck cancer	0.000679	0.00304	CcSEcCtD
Levetiracetam—Nausea—Hydroxyurea—head and neck cancer	0.000656	0.00293	CcSEcCtD
Levetiracetam—Feeling abnormal—Fluorouracil—head and neck cancer	0.000655	0.00293	CcSEcCtD
Levetiracetam—Leukopenia—Docetaxel—head and neck cancer	0.000629	0.00281	CcSEcCtD
Levetiracetam—Body temperature increased—Fluorouracil—head and neck cancer	0.000628	0.00281	CcSEcCtD
Levetiracetam—Cough—Docetaxel—head and neck cancer	0.000613	0.00274	CcSEcCtD
Levetiracetam—Convulsion—Docetaxel—head and neck cancer	0.000609	0.00272	CcSEcCtD
Levetiracetam—Myalgia—Docetaxel—head and neck cancer	0.000598	0.00267	CcSEcCtD
Levetiracetam—Chest pain—Docetaxel—head and neck cancer	0.000598	0.00267	CcSEcCtD
Levetiracetam—Arthralgia—Docetaxel—head and neck cancer	0.000598	0.00267	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000594	0.00266	CcSEcCtD
Levetiracetam—Hypersensitivity—Fluorouracil—head and neck cancer	0.000585	0.00262	CcSEcCtD
Levetiracetam—Confusional state—Docetaxel—head and neck cancer	0.000578	0.00258	CcSEcCtD
Levetiracetam—Infection—Docetaxel—head and neck cancer	0.00057	0.00255	CcSEcCtD
Levetiracetam—Nervous system disorder—Docetaxel—head and neck cancer	0.000562	0.00251	CcSEcCtD
Levetiracetam—Pruritus—Fluorouracil—head and neck cancer	0.000562	0.00251	CcSEcCtD
Levetiracetam—Thrombocytopenia—Docetaxel—head and neck cancer	0.000561	0.00251	CcSEcCtD
Levetiracetam—Skin disorder—Docetaxel—head and neck cancer	0.000557	0.00249	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—head and neck cancer	0.000547	0.00244	CcSEcCtD
Levetiracetam—Diarrhoea—Fluorouracil—head and neck cancer	0.000544	0.00243	CcSEcCtD
Levetiracetam—Dizziness—Fluorouracil—head and neck cancer	0.000525	0.00235	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000522	0.00234	CcSEcCtD
Levetiracetam—Insomnia—Docetaxel—head and neck cancer	0.000519	0.00232	CcSEcCtD
Levetiracetam—Paraesthesia—Docetaxel—head and neck cancer	0.000515	0.0023	CcSEcCtD
Levetiracetam—Somnolence—Docetaxel—head and neck cancer	0.00051	0.00228	CcSEcCtD
Levetiracetam—Vomiting—Fluorouracil—head and neck cancer	0.000505	0.00226	CcSEcCtD
Levetiracetam—Dyspepsia—Docetaxel—head and neck cancer	0.000505	0.00226	CcSEcCtD
Levetiracetam—Rash—Fluorouracil—head and neck cancer	0.000501	0.00224	CcSEcCtD
Levetiracetam—Dermatitis—Fluorouracil—head and neck cancer	0.0005	0.00224	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—head and neck cancer	0.000498	0.00223	CcSEcCtD
Levetiracetam—Headache—Fluorouracil—head and neck cancer	0.000498	0.00223	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000495	0.00221	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—head and neck cancer	0.000494	0.00221	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—head and neck cancer	0.00049	0.00219	CcSEcCtD
Levetiracetam—Pain—Docetaxel—head and neck cancer	0.00049	0.00219	CcSEcCtD
Levetiracetam—Feeling abnormal—Docetaxel—head and neck cancer	0.000473	0.00211	CcSEcCtD
Levetiracetam—Nausea—Fluorouracil—head and neck cancer	0.000472	0.00211	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000469	0.0021	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—head and neck cancer	0.000453	0.00203	CcSEcCtD
Levetiracetam—Abdominal pain—Docetaxel—head and neck cancer	0.000453	0.00203	CcSEcCtD
Levetiracetam—Hypersensitivity—Docetaxel—head and neck cancer	0.000422	0.00189	CcSEcCtD
Levetiracetam—Asthenia—Docetaxel—head and neck cancer	0.000411	0.00184	CcSEcCtD
Levetiracetam—Pruritus—Docetaxel—head and neck cancer	0.000406	0.00181	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—head and neck cancer	0.000392	0.00175	CcSEcCtD
Levetiracetam—Dizziness—Docetaxel—head and neck cancer	0.000379	0.0017	CcSEcCtD
Levetiracetam—Vomiting—Docetaxel—head and neck cancer	0.000365	0.00163	CcSEcCtD
Levetiracetam—Rash—Docetaxel—head and neck cancer	0.000362	0.00162	CcSEcCtD
Levetiracetam—Dermatitis—Docetaxel—head and neck cancer	0.000361	0.00161	CcSEcCtD
Levetiracetam—Headache—Docetaxel—head and neck cancer	0.000359	0.00161	CcSEcCtD
Levetiracetam—Nausea—Docetaxel—head and neck cancer	0.000341	0.00152	CcSEcCtD
